Related Experiment Videos
Brain metastases from malignant melanoma
Vanna Chiarion-Sileni1, Rita Murr, Jacopo Pigozzo
1Oncology Department, Busonera Hospital, Padova, Italy.
Forum (Genoa, Italy)
|January 21, 2004
Summary
Melanoma can spread to the central nervous system (CNS), causing symptoms like headaches. Early detection via MRI and combined treatments improve outcomes for patients with brain metastases.
Area of Science:
- Neuro-oncology
- Medical Oncology
Background:
- Melanoma commonly metastasizes to the central nervous system (CNS) via the bloodstream.
- CNS metastases are found in 10-40% of clinical melanoma cases and up to 90% in autopsy studies.
- New neurological symptoms in melanoma patients warrant suspicion of brain metastases.
Purpose of the Study:
- To summarize the incidence, diagnosis, and treatment of melanoma with CNS metastases.
- To highlight the importance of considering CNS involvement in melanoma patients with neurological deficits.
Main Methods:
- Review of clinical and autopsy studies on melanoma CNS metastases.
- Discussion of diagnostic imaging techniques, primarily Magnetic Resonance Imaging (MRI).
- Overview of current therapeutic strategies including surgery, radiosurgery, radiotherapy, and chemotherapy.
Main Results:
- Headache is the most frequent presenting symptom of CNS metastases.
- MRI is the preferred diagnostic modality for detecting brain metastases.
- Median survival for melanoma patients with CNS metastases is 2-8 months.
Conclusions:
- Prompt diagnosis and multimodal treatment are crucial for managing melanoma with CNS metastases.
- Treatment aims to prolong remission and alleviate symptoms effectively.
- Integrated therapeutic approaches offer the best chance for improved patient outcomes.